Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00333047
Status:
COMPLETED
Last Update Posted:
2009-11-19
First Post:
2006-05-31
Brief Title:
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Study of Letrozole in the Treatment of Metastatic Breast Cancer in Combination With Chemotherapy
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Therapeutic interventions for patients with metastatic breast cancer are aimed at prolonging survival and improving the quality of life The objective of this trial is to assess if an initial chemotherapy followed by an endocrine therapy leads to a longer disease-free interval as compared to chemotherapy alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None